Product
Vocabria + Rekambys
1 clinical trial
1 indication
Indication
HIV-1 InfectionClinical trial
Implementation of Out-of-HOspital Administration of the Long-Acting Combination Cabotegravir+Rilpivirine as an Optional Therapy in HIV-Infected Patients From Spain: Acceptability, Appropriateness, Feasibility and Satisfaction: The HOLA StudyStatus: Recruiting, Estimated PCD: 2025-03-01